This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. This edition of the Drug Discovery TOE depicts trends across clinical pharmacogenomics exemplified with prospective innovations worldwide. Although still much research needs to be carried out to leverage genomic information in the development of more personalized and cost-effective strategies in drug discovery and development, the impact of clinica...

    $950.00
  2. This edition of Genetic Technology TOE profiles trends across skin analytics technologies that can be expected to enable early melanoma detection in the future. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and adv...

    $250.00
  3. 11 Nov 2016  |  North America

    Global Analysis of the Neonatal (Preterm) Care Equipment Market

    A Holistic Approach to Preterm Health and Wellbeing

    The neonatal devices market will continue to be shaped by the regional and local trends in the annual live births and infrastructure market. The industry is undergoing changes in regards to regulatory protocols, preventive care, reimbursement models, healthcare digitization, patient interests, physician preferences, and executive priorities. Stakeh...

    $4,950.00
  4. 11 Nov 2016  |  North America

    Global Orphan Drug Market

    High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs

    The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

    $6,000.00
  5. 11 Nov 2016  |  Asia Pacific

    Analysis of the Australian Clinical Laboratory Market

    Evolving Business Model—Technological Advances will Drive the Market

    Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...

    $1,500.00
  6. 11 Nov 2016  |  Asia Pacific

    Analysis of Percutaneous Coronary Interventions (PCI) Market in Association of Southeast Asian Nations (ASEAN)

    New Technologies Adoption Aiding the High Growth

    The study contains data about three major segments in the Percutaneous Coronary Interventional (PCI) market in the Association of Southeast Asian Nations (ASEAN) market, which are coronary stents, consumables, and embolic protection devices. Cardiac devices are conventionally developed to address major cardiac ailments such as heart blocks. They ar...

    $1,500.00
  7. 09 Nov 2016  |  North America

    US Robotic-assisted Surgery Market, 2016

    As a Third Generation of Technology Emerges, Where is the Market Headed?

    This research traces the history of the first clinical applications for robotic devices and all associated technology required to create a true robotic-assisted surgical device (RASD). The study examines the people (leaders) and entities that became pioneers and founders of the RASD industry vertical. With fundamental original equipment manufacture...

    $4,950.00
  8. 09 Nov 2016  |  North America

    New Paradigms Driving Digital Health Deals and Partnerships

    Healthcare Transformation and Industry Convergence

    Digital technologies are critical enablers of healthcare transformation but organizations vary greatly in their capabilities to deliver new solutions needed to capture growing market opportunities. The imperative to rapidly bring on new IT capabilities as well as to continually adapt and innovate in a highly dynamic environment is driving a wide ar...

    $1,500.00
  9. 08 Nov 2016  |  North America

    The US Molecular Diagnostics Market, Forecast to 2021

    Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye

    The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

    $4,950.00
  10. This edition of Genetic TOE depicts nanotechnological and molecular advances in point-of-care and healthcare settings. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in...

    $1,500.00